Mucosis BV
🇳🇱Netherlands
- Country
- 🇳🇱Netherlands
- Ownership
- Private
- Established
- 2006-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.mucosis.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Phase I Study for SynGEM, an Intranasal Respiratory Syncytial Virus (RSV) Prefusion F Subunit Candidate Vaccine
Phase 1
- Conditions
- Respiratory Syncytial Viral Infections
- First Posted Date
- 2016-11-08
- Last Posted Date
- 2017-09-08
- Lead Sponsor
- Mucosis BV
- Target Recruit Count
- 48
- Registration Number
- NCT02958540
- Locations
- 🇬🇧
Imperial Centre for Translational and Experimental Medicine Hammersmith Hospital, London, United Kingdom
News
No news found